UAE,

April 2020

The UAE’s pharma market was predicted to grow to USD four billion in 2020, representing a CAGR of 8.5 percent from 2019. The country sits at the heart of the Middle East which, although only making up two percent of the global pharmaceutical industry, has been growing at a rate of ten percent and is therefore increasingly attracting the eye of international investors.

With the full fallout of the global coronavirus pandemic still unknown as of April 2020, the UAE nevertheless seems set to remain a highly sought-after investment destination for the foreseeable future. A raft of multinational pharma companies are basing management for vast regions from the UAE thanks to its stability and openness compared to that of its neighbours, well-developed infrastructure, and attractiveness to top talent.

Moreover, the UAE’s welcoming embrace of disruptive technologies is a key selling point and its regulatory body is increasingly open to the early introduction of globally cutting-edge treatments and therapies.

Articles

The UAE: Early Adopters of Cutting-Edge Medical Technology

In some respects, is it perhaps the medtech sector that has most to be excited about in the UAE’s domestic market, given the country’s unrelenting enthusiasm for connected devices, the Internet of Things (IoT) and digital solutions. According to a recent study carried out by INSEAD in conjunction with the World Economic Forum, the UAE…

Embracing Innovation: The UAE as an Initial Product Launch Platform

The UAE’s distinctive willingness to embrace innovation and the ‘can-do’ spirit of authorities marks the country out as worthy of attention as an initial product launch platform. “Along with fellow GCC members, Kuwait and Saudi Arabia, the UAE is notable for its accelerated regulatory pathways. Due to these mechanisms, we often find ourselves able…

The UAE: Becoming a Global Pharma Management Hub

From Turkey to Tajikistan, Bangladesh to Bahrain, and Russia to Rwanda, multinational pharma firms are increasingly situating wide-ranging management responsibilities in the UAE. The following is an inexhaustive list of some of the widely varying geographies being managed from the UAE, as well as insights from the executives overseeing them. Merck Middle East, Africa,…

UAE to Boost Health Research Capabilities as Part of 50-Year Strategy

The United Arab Emirates’ Cabinet, the de facto executive branch of the federation, recently announced a set of decisions and legislation to support health research as a pillar of the country’s 50-year plan. The measures intend to support the healthcare sector, improve its quality and performance. They include a resolution to establish the National…

The UAE’s Fight Against Genetic Diseases

With a relatively high number of genetic disorders, the Arab population of the United Arab Emirates (UAE) is increasingly becoming the subject of new studies. The database from the Center for Arab Genomics Studies indicates the presence of 241 genetic disorders among that demographic, a number they call “extremely high by any standards,” considering the…

UAE: A World Leader for Early Access to Innovation

The UAE ranks as a world leader in rapid drug approvals with its fast-track registration system that accelerates the process and eliminates long waiting times for innovative and orphan drugs. If you bring innovation, the [UAE] government will support you on all levels Georg Schroeckenfuchs, Novartis In January 2018 the Ministry of Health and…